desipramine has been researched along with 1-naphthylamine in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.67) | 18.7374 |
| 1990's | 27 (90.00) | 18.2507 |
| 2000's | 1 (3.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Kriete, M; Rapoport, JL; Ryland, DH | 1 |
| Grealy, M; O'Donnell, JM | 1 |
| Doogan, DP | 1 |
| Curtis, AL; Valentino, RJ | 1 |
| Fischette, CT; Reith, ME; Wiener, HL | 1 |
| Ball, WA; Gresch, PJ; Morrison, AR; Ross, RJ | 1 |
| Ball, WA; Gresch, PJ; Levitt, DR; Morrison, AR; Ross, RJ | 1 |
| Curtis, AL; Parris, DG; Valentino, RJ; Wehby, RG | 1 |
| Butler, J; Leonard, BE; Tannian, M | 1 |
| Fabian, A; Fields, HL; Pazoles, CJ; Taiwo, YO | 1 |
| Duman, RS; Morinobu, S; Nibuya, M | 1 |
| Coutaux, AF; Mooney, JJ; Wirth, DF | 1 |
| Alderman, J; Chung, M; Harris, S; Harrison, W; Messig, M; Preskorn, SH | 1 |
| Asnis, G; Barros, J | 1 |
| Overstreet, DH; Pucilowski, O | 1 |
| Calabrese, JR; Rapport, DJ | 1 |
| Anton, RF; Cunningham, T; Lydiard, RB | 1 |
| Goodman, WK; McDougle, CJ; Price, LH | 1 |
| Freeman, EW; Rickels, K; Sondheimer, SJ; Wittmaack, FM | 1 |
| Burke, MJ; Harvey, AT; Preskorn, SH | 1 |
| Duman, RS; Nestler, EJ; Nibuya, M | 1 |
| Preskorn, SH | 1 |
| Berman, R; Charney, DS; Delgado, PL; Heninger, GR; Krystal, JH; Miller, HL; Salomon, RM | 1 |
| Acquadro, MA; Montgomery, WW | 1 |
| Ahern, D; Ball, SE; Kao, J; Scatina, J | 1 |
| Alderman, J; Allison, J; Chung, M; Greenblatt, DJ; Harrison, W; Penenberg, D; Preskorn, SH | 1 |
| Bergstrom, RF; Cerimele, BJ; Goldberg, MJ; Kurtz, DL | 1 |
| Anand, A; Barr, LC; Goodman, WK; McDougle, CJ; Price, LH | 1 |
| Bagby, RM; Dickens, SE; Joffe, R; Kennedy, SH; Levitt, A; Minifie, CE; Schuller, DR | 1 |
4 review(s) available for desipramine and 1-naphthylamine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Toleration and safety of sertraline: experience worldwide.
Topics: 1-Naphthylamine; Amitriptyline; Antidepressive Agents; Depressive Disorder; Desipramine; Drug Overdose; Humans; Risk Factors; Sertraline | 1991 |
Pharmacology of locus coeruleus spontaneous and sensory-evoked activity.
Topics: 1-Naphthylamine; Action Potentials; Animals; Antidepressive Agents; Corticotropin-Releasing Hormone; Depression; Depression, Chemical; Desipramine; Drug Tolerance; Electroshock; Humans; Hypothalamo-Hypophyseal System; Locus Coeruleus; Mianserin; Nitroprusside; Pain; Rats; Sertraline; Stress, Physiological | 1991 |
The pharmacotherapy of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Buspirone; Clomipramine; Desipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
8 trial(s) available for desipramine and 1-naphthylamine
| Article | Year |
|---|---|
Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Animals; Clomipramine; Dermatitis; Desipramine; Disease Models, Animal; Dog Diseases; Dogs; Double-Blind Method; Fenfluramine; Fluoxetine; Follow-Up Studies; Grooming; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Serotonin; Sertraline; Ulcer | 1992 |
Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.
Topics: 1-Naphthylamine; Antidepressive Agents; Chromatography, High Pressure Liquid; Desipramine; Dextromethorphan; Drug Interactions; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.
Topics: 1-Naphthylamine; Adolescent; Adult; Depressive Disorder; Desipramine; Double-Blind Method; Female; Humans; Middle Aged; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 1996 |
Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Brain Chemistry; Depressive Disorder; Desipramine; Diphenhydramine; Dopamine; Fluoxetine; Humans; Mazindol; Methyltyrosines; Norepinephrine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Area Under Curve; Cross-Over Studies; Desipramine; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Humans; Male; Middle Aged; Paroxetine; Sertraline | 1997 |
The effect of sertraline on the pharmacokinetics of desipramine and imipramine.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Tricyclic; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Desipramine; Half-Life; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Adult; Clomipramine; Desipramine; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Analysis of Variance; Anger; Cyclohexanols; Depressive Disorder; Desipramine; Female; Hostility; Humans; Male; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
18 other study(ies) available for desipramine and 1-naphthylamine
| Article | Year |
|---|---|
Neuroendocrine response to clonidine and 8-OH-DPAT in rats following chronic administration of desipramine or sertraline.
Topics: 1-Naphthylamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Cerebral Cortex; Clonidine; Corticosterone; Desipramine; Dihydroalprenolol; Male; Neurosecretory Systems; Prolactin; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sertraline; Tetrahydronaphthalenes | 1992 |
Sertraline and cocaine-induced locomotion in mice. I. Acute studies.
Topics: 1-Naphthylamine; Animals; Cocaine; Desipramine; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neurons; Serotonin; Serotonin Antagonists; Sertraline; Sex Factors | 1991 |
REM sleep suppression by monoamine reuptake blockade: development of tolerance with repeated drug administration.
Topics: 1-Naphthylamine; Animals; Brain; Cats; Circadian Rhythm; Desipramine; Dose-Response Relationship, Drug; Female; Naphthalenes; Receptors, Adrenergic; Receptors, Serotonin; Serotonin Antagonists; Sertraline; Sleep, REM | 1990 |
Effects of monoamine reuptake blockade on ponto-geniculo-occipital wave activity.
Topics: 1-Naphthylamine; Animals; Biological Transport; Cats; Desipramine; Electroencephalography; Electromyography; Electrooculography; Eye Movements; Female; Geniculate Bodies; Norepinephrine; Occipital Lobe; Pons; Serotonin; Serotonin Antagonists; Sertraline; Sleep, REM | 1990 |
Antidepressant actions on brain noradrenergic neurons.
Topics: 1-Naphthylamine; Animals; Brain; Corticotropin-Releasing Hormone; Desipramine; Dose-Response Relationship, Drug; Evoked Potentials, Somatosensory; Injections, Intravenous; Male; Naphthalenes; Neural Conduction; Rats; Rats, Inbred Strains; Sciatic Nerve; Serotonin Antagonists; Sertraline | 1990 |
The chronic effects of desipramine and sertraline on platelet and synaptosomal 5HT uptake in olfactory bulbectomised rats.
Topics: 1-Naphthylamine; Amygdala; Animals; Blood Platelets; Cerebral Cortex; Desipramine; Male; Motor Activity; Naphthalenes; Olfactory Bulb; Rats; Rats, Inbred Strains; Reference Values; Serotonin; Serotonin Antagonists; Sertraline; Synaptosomes | 1988 |
Potentiation of morphine antinociception by monoamine reuptake inhibitors in the rat spinal cord.
Topics: 1-Naphthylamine; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Desipramine; Drug Synergism; Male; Morphine; Nociceptors; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Sertraline; Spinal Cord | 1985 |
Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex.
Topics: 1-Naphthylamine; Amino Acid Isomerases; Animals; Antidepressive Agents; Carrier Proteins; Desipramine; Down-Regulation; Frontal Lobe; Imipramine; Male; Peptidylprolyl Isomerase; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Restraint, Physical; RNA, Messenger; Sertraline; Stress, Psychological; Time Factors; Tranylcypromine | 1995 |
Neuronal monoamine reuptake inhibitors enhance in vitro susceptibility to chloroquine in resistant Plasmodium falciparum.
Topics: 1-Naphthylamine; Animals; Chloroquine; Desipramine; Drug Resistance; Drug Synergism; Fluoxetine; Neurotransmitter Uptake Inhibitors; Plasmodium falciparum; Sertraline | 1994 |
An interaction of sertraline and desipramine.
Topics: 1-Naphthylamine; Depressive Disorder; Desipramine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Effect of chronic antidepressant treatment on responses to apomorphine in selectively bred rat strains.
Topics: 1-Naphthylamine; Animals; Apomorphine; Body Temperature Regulation; Breeding; Depressive Disorder; Desipramine; Disease Models, Animal; Male; Motor Activity; Parasympathetic Nervous System; Rats; Sertraline; Time Factors | 1993 |
Tolerance to fluoxetine.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Interactions between sertraline and tricyclic antidepressants.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Drug Interactions; Humans; Imipramine; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Pharmacokinetics of the newer antidepressants.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Desipramine; Fluoxetine; Humans; Isoenzymes; Liver; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.
Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Base Sequence; Blotting, Northern; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Desipramine; Electric Stimulation; Fluoxetine; Hippocampus; Imipramine; In Situ Hybridization; Male; Molecular Sequence Data; Nerve Growth Factors; Nerve Tissue Proteins; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, trkB; Receptors, Nerve Growth Factor; RNA, Messenger; Rolipram; Sertraline; Time Factors; Tranylcypromine | 1996 |
Drug-drug interactions.
Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Mixed Function Oxygenases; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Treatment of chronic paranasal sinus pain with minimal sinus disease.
Topics: 1-Naphthylamine; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Carbamazepine; Chronic Disease; Desipramine; Humans; Migraine Disorders; Pain; Paranasal Sinuses; Selective Serotonin Reuptake Inhibitors; Sertraline; Sinusitis; Trigeminal Neuralgia | 1996 |
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride | 1997 |